Background and rationale for mechanism of action, efficacy, and safety of fingolimod (Gilenya), the first oral therapy for remitting-relapsing multiple sclerosis
Huggins, Alison, Sergott, Robert C.Volume:
22
Language:
english
Journal:
Current Opinion in Ophthalmology
DOI:
10.1097/ICU.0b013e32834be03b
Date:
November, 2011
File:
PDF, 101 KB
english, 2011